ARTAÇ, M. Et Al. 2013. Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs). BREAST CANCER , vol.20, no.2 , 174-180.

ARTAÇ, M., Bozcuk, H., Kiyici, A., Eren, O. O., Boruban, M. C., & Ozdogan, M., (2013). Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs). BREAST CANCER , vol.20, no.2, 174-180.

ARTAÇ, MEHMET Et Al. "Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs)," BREAST CANCER , vol.20, no.2, 174-180, 2013

ARTAÇ, MEHMET Et Al. "Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs)." BREAST CANCER , vol.20, no.2, pp.174-180, 2013

ARTAÇ, M. Et Al. (2013) . "Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs)." BREAST CANCER , vol.20, no.2, pp.174-180.

@article{article, author={MEHMET ARTAÇ Et Al. }, title={Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs)}, journal={BREAST CANCER}, year=2013, pages={174-180} }